ResultsIQ

ResultsIQ › Latest results › Usha Martin Limited

Usha Martin Limited Q2 FY27 results press release summary

NSE: USHAMART · BSE: 517146

Results press release of 13 Nov 2026, summarised by AI from the filing.

Management expects a stronger second half on healthy domestic demand and specialised product progress.

Key takeaways

  1. Second half Management expects a stronger second half on healthy domestic demand and specialised product progress.
  2. Elevator rope Commissioning of the elevator rope capacity expansion has commenced, with full incremental capacity expected by Q1 FY28.
  3. Product mix Improved product mix, better domestic realisations and cost management supported profitability.
  4. West Asia Geopolitical uncertainties and elevated freight costs continued to impact West Asia volumes.

Original filing on BSE

Usha Martin Limited Q2 FY27 results

As filed: Revenue ₹1,000 cr (+10% year on year), EBITDA ₹202 cr (+17% year on year), PAT ₹124 cr (+13% year on year), EBITDA margin 20.2% (+114 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹1,033 cr (+16% year on year), EBITDA ₹208 cr (+43% year on year), PAT ₹142 cr (+41% year on year), EBITDA margin 20.1% (+379 bps). Score 85 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 379 bps year on year. Profit fell 4% from last quarter. Share price after the results: −1.2% in 30 days (Nifty 500: +1.8%).
  • Q4 FY26: Revenue ₹979 cr (+9% year on year), EBITDA ₹212 cr (+51% year on year), PAT ₹148 cr (+47% year on year), EBITDA margin 21.6% (+598 bps). Score 88 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 598 bps year on year. Share price after the results: +9.6% in 29 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹917 cr (+7% year on year), EBITDA ₹176 cr (+23% year on year), PAT ₹108 cr (+31% year on year), EBITDA margin 19.2% (+258 bps). Score 75 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit before exceptional items growth were well above it. EBITDA margin rose 258 bps year on year. Profit fell 10% from last quarter. Share price after the results: +2.4% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹908 cr (+2% year on year), EBITDA ₹173 cr (+7% year on year), PAT ₹110 cr (+1% year on year), EBITDA margin 19.1% (+98 bps). Score 51 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA growth was above it; profit growth was in line with it. EBITDA margin rose 98 bps year on year. Share price after the results: −11.7% in 30 days (Nifty 500: 0.0%).
  • Q1 FY26: Revenue ₹887 cr (+7% year on year), EBITDA ₹145 cr (−6% year on year), PAT ₹101 cr (−3% year on year), EBITDA margin 16.4% (−242 bps). Score 44 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 242 bps year on year. Share price after the results: +9.5% in 30 days (Nifty 500: +2.4%).
  • Q4 FY25: Revenue ₹896 cr (+8% year on year), EBITDA ₹140 cr (−9% year on year), PAT ₹101 cr (−5% year on year), EBITDA margin 15.6% (−283 bps). Score 42 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 283 bps year on year. Share price after the results: +5.9% in 30 days (Nifty 500: +7.7%).
  • Q3 FY25: Revenue ₹861 cr (+8% year on year), EBITDA ₹143 cr (−9% year on year), PAT ₹92.0 cr (−15% year on year), EBITDA margin 16.6% (−309 bps). Score 33 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 309 bps year on year. Revenue fell 3% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Usha Martin Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.